TrialThe journal of headache and pain2020

The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study.

Stephen D Silberstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.